SPRING DNA
LIVE

Serial Number

97801754

Owner

AVECRIS PTE. LTD.

Filing Date

Feb 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SPRING DNA Trademark

Serial Number: 97801754

SPRING DNA is a trademark filed by AVECRIS PTE. LTD. on February 19, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

AVECRIS PTE. LTD.

2 Jurong East Street 21
Singapore 609601 , SG

Entity Type: 99

Trademark Details

Filing Date

February 19, 2023

Registration Date

Not Registered

Goods & Services

Development of gene-based medicines; Development of pharmaceutical preparations and medicines; Gene therapy research; Genetic testing for scientific research purposes; Laboratory research in the field of gene expression, gene editing, RNAi and nucleic acid sciences; Research and development in the field of gene expression systems, gene delivery, genetic vector, DNA vectors, non-viral genetic vectors, diagnostics, cosmetics, RNAi, mRNA, synthetic DNA manufacturing, in vitro transcription, gene editing, genetic vaccination, immunology, gene therapy, oncology, RNA trans-splicing, linear DNA, hairpin DNA, dumbbell DNA, plasmids, RNA, mitochondrial gene therapy, polymerase chain reaction, ligands, conjugates, helper functions, aptamers, antibodies, gap primers, gap primer PCR; Research and development of vaccines; Vaccine research and development; Product development in the field of gene-based medicines, gene therapy, diagnostics and genetic vaccination; Providing information about medical research in the field of gene therapy and genetic vaccination; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing scientific research information in the field of genetic vaccination, gene therapy, and diagnostics; Research and development of vaccines and medicines; Research and development services in the field of gene expression systems; Research in the field of gene editing technology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for gene therapy and genetic vaccination

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Aug 18, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Aug 18, 2025 WOAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2023 NWOS
NEW APPLICATION ENTERED
Feb 22, 2023 NWAP